Sarepta Therapeutics (NasdaqGS:SRPT) saw its share price rise by 19% over the past month, a move that notably outpaced the broader market's 1% increase for the week and the 13% gain over the year.

Sarepta Therapeutics SRPT announced that the FDA has granted platform-technology designation to its viral vector rAAVrh74, ...

The Platform Technology Designation, which predates the current FDA leadership, is designed to streamline the drug ...

A Sarepta police officer has been arrested in connection with an incident where a dog was shot and killed last month.

Fintel reports that on June 6, 2025, Scotiabank upgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from Sector ...

Interim results from a small group of children in a Phase I/II trial are essentially in line with that of Elevidys, according ...

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

RegenXBio has shared updated phase 1/2 data on its Duchenne muscular dystrophy (DMD) gene therapy, providing evidence that ...

The Webster Parish Sheriff's Office is investigating two officers in two different towns accused of shooting dogs.

A Sarepta police officer has been arrested in connection with an incident where a dog was shot and killed last month.

A Sarepta, LA police officer has been arrested in connection with an incident where a dog was shot and killed last month.

Sarepta Therapeutics’ gene therapy to treat limb girdle muscular dystrophy type 2E/R4 gets US FDA platform technology designation: Cambridge, Massachusetts Friday, June 6, 2025, ...